Seppo Jalava
Seppo Jalava publishes mostly in Rheumatology, Surgery and Pulmonary and Respiratory Medicine, on topics such as Musculoskeletal synovial abnormalities and treatments, Rheumatoid Arthritis Research and Therapies and Inflammatory mediators and NSAID effects.
- World rank
- #7,368,839 of 7,710,434 ranked researchers
- Rank in Finland
- #36,730 of 37,370
- Works
- 28
- Citations
- 340
- Citations per work
- 12.1
What does Seppo Jalava research?
Seppo Jalava's work is mostly in Medicine (58%), Immunology and Microbiology (5%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1658.0%
- Medicine1658.0%
- Everything else1037.1%
- Life Sciences14.9%
- 1Rheumatology28% of their works
- 2Surgery9% of their works
- 3Pulmonary and Respiratory Medicine7% of their works
- 4Pharmacology7% of their works
- 5Epidemiology6% of their works
- 6Immunology5% of their works
Research topics
- Musculoskeletal synovial abnormalities and treatments
- Rheumatoid Arthritis Research and Therapies
- Inflammatory mediators and NSAID effects
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Inflammatory Myopathies and Dermatomyositis
- HER2/EGFR in Cancer Research
- Medical Imaging and Pathology Studies
- Elbow and Forearm Trauma Treatment
Which keywords describe Seppo Jalava's research?
The keywords of their largest research topics: Cardiovascular Risk, Inflammation, Autoantibodies, Pigmented Villonodular Synovitis, Synovial Chondromatosis, Biological Therapy, Rheumatoid Arthritis and Interstitial Lung Disease.
- Ulnar Collateral Ligament Reconstruction
- Pulmonary Alveolar Microlithiasis
- HER2
- Dermatomyositis
- Idiopathic Pulmonary Fibrosis
- Cyclooxygenase-2 Inhibitors
- Interstitial Lung Disease
- Biological Therapy
- Pigmented Villonodular Synovitis
- Inflammation
- Cardiovascular Risk
- Autoantibodies
- Synovial Chondromatosis
- Rheumatoid Arthritis
- Cancer
- Fibrosis
- Breast Cancer
- Elbow Injuries
- Inflammatory Myopathies
- Pulmonary Sclerosing Hemangioma
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 20 words, with their numbers
- Cardiovascular Risk112 topics
- Inflammation112 topics
- Autoantibodies92 topics
- Pigmented Villonodular Synovitis81 topic
- Synovial Chondromatosis81 topic
- Biological Therapy71 topic
- Rheumatoid Arthritis71 topic
- Interstitial Lung Disease52 topics
- Cancer41 topic
- Cyclooxygenase-2 Inhibitors41 topic
- Fibrosis31 topic
- Idiopathic Pulmonary Fibrosis31 topic
- Breast Cancer21 topic
- Dermatomyositis21 topic
- Elbow Injuries21 topic
- HER221 topic
- Inflammatory Myopathies21 topic
- Pulmonary Alveolar Microlithiasis21 topic
- Pulmonary Sclerosing Hemangioma21 topic
- Ulnar Collateral Ligament Reconstruction21 topic
Where does Seppo Jalava work?
Seppo Jalava's main affiliation in the publication record is University of Turku, Finland.
How many publications and citations does Seppo Jalava have?
OpenAlex counts 28 works and 340 citations for Seppo Jalava, an h-index of 11, ranking #7,368,839 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Seppo Jalava. Posts are plain text and can be reported.